Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo), Following 3 Doses of Active Drug (CDP870).

This study has been completed.
Information provided by:
UCB Pharma Identifier:
First received: September 7, 2005
Last updated: September 6, 2013
Last verified: July 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2005
  Primary Completion Date: May 2005 (Final data collection date for primary outcome measure)

Publications automatically indexed to this study by Identifier (NCT Number):